Radiation blast before supercharged cells: new hope for tough lymphomas
NCT ID NCT05514327
Summary
This study is testing a two-part treatment for a type of blood cancer called diffuse large B-cell lymphoma that has come back or hasn't responded to standard chemotherapy. First, patients receive a short, intense course of radiation therapy. Then, they receive a personalized cell therapy called CAR-T, which uses the patient's own modified immune cells to attack the cancer. The main goal is to see if this combination is safe and helps control the cancer for at least three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.